StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Who should receive experimental treatment (of Ebola) - Essay Example

Cite this document
Summary
It was disclosed by the World Health Organization that it had recorded around 4,300 cases of its incidence as of 9 September 2014. Since, a large number of infected people die at home, this…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER97.3% of users find it useful
Who should receive experimental treatment (of Ebola)
Read Text Preview

Extract of sample "Who should receive experimental treatment (of Ebola)"

of the of the Recipients of Experimental Treatment for Ebola Recipients of Experimental Treatment for Ebola Introduction"Experimental treatment should be need based rather than being based on nationality or race."The following discussion proves this contention. The Ebola virus has been increasingly causing death among the people of West Africa. It was disclosed by the World Health Organization that it had recorded around 4,300 cases of its incidence as of 9 September 2014. Since, a large number of infected people die at home, this estimate has been regarded as a gross underestimation.

In fact, some entities had placed the number of deaths due to the Ebola virus at 12,000 (The Economist, 2014, p. 85). The extant drugs for treating Ebola virus infections are in the experimental stages of development. In the absence of approval for a drug, the Food and Drugs Administration (FDA) can permit access to latently promising drugs, via other channels. One such mechanism is the emergency Investigational New Drug (IND) initiative (Centers for Disease Control and Prevention, 2014). The Ebola virus has been principally restricted to underdeveloped nations of the world.

Consequently, no vaccine or drug to address it has been produced, despite its presence for nearly four decades. The current outbreak of this disease has been of such gravity that the developed nations have been seriously striving to produce vaccines and drugs to deal with it. The rapidity with which this dread infection is spreading has necessitated an approach that ignores the existing rules governing the delivery of new drugs. The WHO clearly stated that when certain conditions were satisfied, it would not be unethical to provide vaccines and drugs, in the experimental stage to prevent infection (The Economist, 2014, p. 85). The experimental serum ZMapp, developed by the US, was injected to two missionaries of the US, after they had been infected with the Ebola virus in Liberia.

These missionaries were subsequently relocated to the US and were undergoing treatment in that nation. In the aftermath of this incident, the WHO conducted a meeting to discuss the ethical issues involved in administering experimental drugs to individuals infected with the Ebola virus (Dionne, 2014). In addition, this drug had also been given to a small number of US health officials who had been infected with the Ebola virus in West Africa. The apparent success of this drug in combating the dread Ebola virus induced the US health officials to ask some of the most advanced biology laboratories to present it with plans for producing it (The Guardian, 2014).

As such, the provision of healthcare is biased, and the above evidence demonstrates it adequately. The American missionaries had been given the promising new drug, whereas no attempt was being made to succor the large number of infected people of West Africa. Evidently, the life of a white American was deemed to be worth much more than that of a black African hailing from some of the least developed regions of the world (Dionne, 2014).Conclusion During epidemics, it is essential to provide rapid treatment for the individuals engaged in critical occupations, such as healthcare workers.

This has been clearly demonstrated with regard to the outbreak of Ebola, which is a highly infectious disease that almost always ends in the death of the infected individual. With regard to drugs in the experimental stage, these should be provided to the healthcare workers and patients of the nation where there is an epidemic of the disease. Morally, the demand of such people on these drugs is the highest. Furthermore, providing these healthcare workers with such drugs, will enable them to recover from the infection and to continue in their efforts to help infected individuals.

As such, this discussion establishes the contention that experimental treatment should be administered, to the people, based on need and not on the basis of their race or nationality. List of ReferencesCenters for Disease Control and Prevention. (2014, August 29). Ebola (Ebola Virus Disease). Retrieved October 21, 2014, from http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/qa-experimental-treatments.htmlDionne, K. Y. (2014, August 10). Ebola experimental treatment only for the exceptional.

Retrieved October 21, 2014, from The Washington Post: http://www.washingtonpost.com/blogs/monkey-cage/wp/2014/08/10/ebola-experimental-treatment-only-for-the-exceptional/The Economist. (2014, September). Fast-tracking treatments: Ebola. The Economist, 412(8904), 85.The Guardian. (2014, October 17). US labs asked for proposals to produce experimental Ebola drug ZMapp. Retrieved from http://www.theguardian.com/world/2014/oct/17/us-labs-proposals-produce-ebola-drug-zmapp

Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Who should receive experimental treatment (of Ebola) Essay”, n.d.)
Who should receive experimental treatment (of Ebola) Essay. Retrieved from https://studentshare.org/business/1660971-who-should-receive-experimental-treatment-of-ebola
(Who Should Receive Experimental Treatment (of Ebola) Essay)
Who Should Receive Experimental Treatment (of Ebola) Essay. https://studentshare.org/business/1660971-who-should-receive-experimental-treatment-of-ebola.
“Who Should Receive Experimental Treatment (of Ebola) Essay”, n.d. https://studentshare.org/business/1660971-who-should-receive-experimental-treatment-of-ebola.
  • Cited: 0 times

CHECK THESE SAMPLES OF Who should receive experimental treatment (of Ebola)

The classification of Ecstacy: come down or stay high

Another notable aspect that was pointed out in this study is the fact that in residential settings, there was a higher incidence of mixed use of ecstasy with other experimental drugs or higher risk drugs which are associated with more damaging and addictive behavior.... Its chemical name is 3,4 methylenedioxymetham-phetamine or MDMA....
20 Pages (5000 words) Essay

Delivering Healthcare to Patients

They point out that language proficiency and communication is essential between provider and patient in… It is only when there is clear and correct communication between a health care provider and the patient that the former can make accurate clinical diagnoses and the latter can be made aware of exactly what his/her medical condition is with the care that can be provided and will thus have the option to freely consent to, or refuse treatment on the basis of complete information....
13 Pages (3250 words) Essay

Effects of flicker on reading comfort

Another name of this group of symptoms is ‘pattern glare' that was used by Wilkins and Nimmo-Smith6 because they induced in normal people, who do not have photosensitive epilepsy, when they observed patterns of strips.... Lambooij, Ijsselsteijn, and Heynderickx1 pointed out that although both terms are linked; visual discomfort is often corresponded with subjective symptoms such as headache and… They enclosed both terms in a single diagnostic term ‘asthenopia'....
16 Pages (4000 words) Essay

Discussion thre

The dilemma in the case of who should receive the experimental drug for Ebola is that on one hand, there is a potential risk… On the other hand, the drug might work and not administering it will allow continued deaths from Ebola.... This is an ethical dilemma because the person, who has the experimental drug, and all other people, Ethics and Consent Ethics and Consent: who should receive the experimental drug for Ebola?... The dilemma in the case of who should receive the experimental drug for Ebola is that on one hand, there is a potential risk that the drug might have adverse effects on those to whom it is administered....
1 Pages (250 words) Assignment

Human and Animal Interrelationships

The results of… Animals contributed to advanced treatment of cancer, brain and heart disorders, arthritis, asthma, diabetes, tuberculosis, genetic disorders, vaccination etc.... Another fatal disease, for which the scientists hope to find the treatment using animal research, is Duchene dystrophy.... There is no treatment for Duchene dystrophy at present, however scientists hope to find one soon with the help of animals, which are used for testing agents, that might help to reverse the deadly processes in muscles....
4 Pages (1000 words) Term Paper

Signs, Symptoms, and Transmission of Ebola

According to the CDC, virologists have not yet precisely identified the natural reservoir host of ebola virus, nonetheless, evidence has overtime pointed towards the fact that the virus is animal borne, with bats being suggested as the most likely reservoir.... Given that researchers have not been able to identify major reservoir host of ebola virus, virologists have customarily found it challenging to pinpoint the start of ebola outbreak.... The disease, which was previously branded as ebola hemorrhagic fever, is known to affect both human beings and nonhuman primates particularly chimpanzees,… More specifically, it is important to note that ebola is caused by an infection that belongs to the family Filoviridae and genus Ebolavirus....
4 Pages (1000 words) Essay

Male Reproductive Health Problems

The author of the present research paper "Male Reproductive Health Problems" outlines that male reproductive health is an important health problem although it does not receive as much attention compared to the other health problems from the United States Centers for Disease Control and Prevention....
7 Pages (1750 words) Research Paper

Breast Magnetic Resonance

The paper "Breast Magnetic Resonance" examines the common image artifacts associated with Breast MRI, and strategies used to minimize them.... The author of this paper focuses on the clinical usefulness of spectroscopy in Breast MRI, strategies used to minimize truncation artifacts, aliasing artifacts....
9 Pages (2250 words) Report
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us